Advocacy for appropriate reimbursement terms and payment rates for biologics under the Medicare and Medicaid programs. Support corporate tax policies which protect US research and manufacturing jobs, including issues related to transfer pricing and R&D credit. Patent Reform -- S. 515 and HR 1260 -- Support for modernizing the patent system while ensuring the ongoing strength and value of intellectual property for biotechnology, with a specific focus on damages provisions, inequitable conduct, and post-grant/second window.  Opposition to inclusion of patent settlements legislation in appropriations bill. 1) Advocacy to reform IPAB to ensure patient access to medically necessary therapies. 
2) Health care reform:  Implementation of the pharmaceutical manufacturer fee
MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 41 - Treasury, Dept of
BIOGEN
601 PENNSYLVANIA AVENUE, NW #720, WASHINGTON, DC, 20004, US
KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committe)
Staff, House Ways and Means Committee Staff, Senate HELP Committee Staff, House Ways and Means Committee Staff, Senate HELP Committee Staff, House Ways and Means Committee Staff, Senate HELP Committee Staff, House Ways and Means Committee Staff, Senate HELP Committe